Do maternally acquired antibodies protect infants from malaria infection?
about
Plasmodium malaria and antimalarial antibodies in the first year of lifeUsing structured additive regression models to estimate risk factors of malaria: analysis of 2010 Malawi malaria indicator survey dataSeasonal variation and high multiplicity of first Plasmodium falciparum infections in children from a holoendemic area in Ghana, West Africa.Determination of the processes driving the acquisition of immunity to malaria using a mathematical transmission modelVivax malaria: a major cause of morbidity in early infancy.Can prenatal malaria exposure produce an immune tolerant phenotype? A prospective birth cohort study in Kenya.High resolution niche models of malaria vectors in northern Tanzania: a new capacity to predict malaria risk?Diagnosing congenital malaria in a high-transmission setting: clinical relevance and usefulness of P. falciparum HRP2-based testing.Effect of IPTp on Plasmodium falciparum antibody levels among pregnant women and their babies in a sub-urban coastal area in GhanaA role for fetal hemoglobin and maternal immune IgG in infant resistance to Plasmodium falciparum malaria.Pregnancy-associated malaria and malaria in infants: an old problem with present consequencesIn vitro growth of Plasmodium falciparum in neonatal bloodImpact of malaria at the end of pregnancy on infant mortality and morbidity.The war between the malaria parasite and the immune system: immunity, immunoregulation and immunopathology.Malaria care in infants aged under six months in Uganda: an area of unmet needs!Patterns of mixed Plasmodium species infections among children six years and under in selected malaria hyper-endemic communities of Zambia: population-based survey observations.Determinants of infant susceptibility to malaria during the first year of life in South Western cameroonProspects and Pitfalls of Pregnancy-Associated Malaria Vaccination Based on the Natural Immune Response to Plasmodium falciparum VAR2CSA-Expressing Parasites.Stool microbiota composition is associated with the prospective risk of Plasmodium falciparum infectionFirst malaria infections in a cohort of infants in Benin: biological, environmental and genetic determinants. Description of the study site, population methods and preliminary results.Anemia and Red Blood Cell Abnormalities in HIV-Infected and HIV-Exposed Breastfed Infants: A Secondary Analysis of the Kisumu Breastfeeding Study.The immunological challenge to developing a vaccine to the blood stages of malaria parasites.Opsonization of malaria-infected erythrocytes activates the inflammasome and enhances inflammatory cytokine secretion by human macrophages.Malaria in infants aged less than six months - is it an area of unmet medical need?Malaria in rural Mozambique. Part I: children attending the outpatient clinicFactors associated with malaria parasitaemia, malnutrition, and anaemia among HIV-exposed and unexposed Ugandan infants: a cross-sectional survey.Maternal-foetal transfer of Plasmodium falciparum and Plasmodium vivax antibodies in a low transmission setting.Targets and Mechanisms Associated with Protection from Severe Plasmodium falciparum Malaria in Kenyan Children.Congenital malaria--a recurrent problem.HIV and co-infections.Influence of iron status on risk of maternal or neonatal infection and on neonatal mortality with an emphasis on developing countries.Performance of rapid diagnostic test, blood-film microscopy and PCR for the diagnosis of malaria infection among febrile children from Korogwe District, Tanzania.Prevalence and diagnostics of congenital malaria in rural Burundi, a cross-sectional study.Cord blood IgG and the risk of severe Plasmodium falciparum malaria in the first year of life.Suppression of vaccine responses by malaria: insignificant or overlooked?Estimating age-time-dependent malaria force of infection accounting for unobserved heterogeneity.Congenital Plasmodium falciparum Malaria in Washington, DC.Can changes in malaria transmission intensity explain prolonged protection and contribute to high protective efficacy of intermittent preventive treatment for malaria in infants?Dynamics of the antibody response to Plasmodium falciparum infection in African children.How selection forces dictate the variant surface antigens used by malaria parasites.
P2860
Q26315542-A42ED605-34DD-41AF-BE55-9AC9C3ADD22EQ30834963-6B74013F-6814-4874-B659-9EAEFA944869Q33241179-51F90766-53E4-453E-AA70-FA747ACE312EQ33312850-13C710A0-3309-41CC-92BF-C2AB58793DA0Q33384482-8EE40CDF-A5D7-4E9E-8FD9-E849628641D3Q33487651-6769D50D-0DEF-4E60-81D6-46067030D276Q33535794-98EE6E29-A436-4E07-9B34-BA69DE459A0AQ33704972-0A645CD8-6CB8-4A18-B463-8AEBD2B12344Q33733730-A6AF7DE4-D7C0-4080-B7A1-0DFB9C5CB5A5Q33885842-E798C496-03F6-4A50-B098-EB8AA6CE2D09Q33963392-2D354767-D3A5-4F56-B2A9-FA30A3508CFDQ34565562-6C1F624B-8DC5-462C-8FE3-065BC16E4854Q34764578-D35FFBC3-DACE-4C03-BFD5-C65FF893E018Q35180114-A3F28D7A-D41D-4A3D-ACFB-BEDE1C94C7BEQ35364680-C0C7EB90-6A96-4039-8871-30DA53690BD3Q35583961-A65D1A67-00A4-4774-ABA7-96837CCC351CQ35628255-91929049-2727-4E93-B986-FC6C57208B06Q35738477-7F0FF935-7EBB-4E63-ACB0-210CB068AECDQ35752634-BAEA86CE-C266-4406-A921-F09F75804C4AQ35819766-8406F786-F18C-44F7-8A48-B79CD2968467Q35830556-6EE79632-CF40-4A3A-9EFD-06A78A0CA429Q35884247-05397D39-85CD-4881-8B43-07C5CBD3DF3CQ36483344-146FC15C-FBC6-4119-A6C6-B57DA48177ECQ36487069-1E4A06D7-084B-4773-9C55-89CF25A3604DQ36498863-BF0396B4-090D-44E9-B3B1-0651BB430A0AQ36531334-12EF10E1-D372-4209-B37A-AD8CA5EC910EQ36565070-FA24BB93-73BD-46E9-A2C3-0CEE65B24F92Q36728063-78C63576-9348-4040-B11C-AD1F118DEB48Q36848323-AB143F8B-1961-4E14-91DC-3B0CDAE3010AQ36970184-CDEE4464-7E2E-47F9-8D60-36820EAEAAEDQ37040734-9FDD1CE1-0101-40FB-8343-92F4B69F23AEQ37129311-0D66C122-0175-4362-B906-7A106BFE8F4FQ37221060-D4973B71-DDCE-49A3-B501-838781646056Q37631228-A5908C8F-D3D3-4B3F-B51A-01CAF095F79EQ37724859-D1403C0F-CFE2-4EE4-AECF-F1403FF1B3FDQ38693387-D4677FFE-16BB-46DB-9304-15D71942A685Q38968844-AEE3E4FB-949A-45BD-AC5B-EFF62F177D54Q39029573-6CEC618A-5B4E-460C-97E8-5771CC9429D2Q39589730-58B556DC-8862-45DB-87AE-6C119AE286E4Q39932709-F0E73384-4356-407C-98A5-2C45B3C9660D
P2860
Do maternally acquired antibodies protect infants from malaria infection?
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Do maternally acquired antibodies protect infants from malaria infection?
@ast
Do maternally acquired antibodies protect infants from malaria infection?
@en
Do maternally acquired antibodies protect infants from malaria infection?
@nl
type
label
Do maternally acquired antibodies protect infants from malaria infection?
@ast
Do maternally acquired antibodies protect infants from malaria infection?
@en
Do maternally acquired antibodies protect infants from malaria infection?
@nl
prefLabel
Do maternally acquired antibodies protect infants from malaria infection?
@ast
Do maternally acquired antibodies protect infants from malaria infection?
@en
Do maternally acquired antibodies protect infants from malaria infection?
@nl
P2093
P2860
P1433
P1476
Do maternally acquired antibodies protect infants from malaria infection?
@en
P2093
P2860
P356
10.1046/J.1365-3024.2001.00364.X
P577
2001-02-01T00:00:00Z